TRICARE For Life and Wegovy Coverage: SEE THE NEW RULES

TRICARE For Life beneficiaries who use Wegovy or other semaglutide injections may see changes in how coverage, prior authorization, and pharmacy copays are handled. The updates can affect whether a prescription is filled at a military pharmacy, through home delivery, or at a retail network pharmacy. Understanding the TRICARE formulary, eligibility rules, and appeals process can help you avoid surprises and keep refills on track.

TRICARE For Life and Wegovy Coverage: SEE THE NEW RULES Image by Lucio Alfonsi from Pixabay

For Medicare-eligible military retirees and their families, TRICARE For Life acts as a wraparound to Medicare Part A and Part B. Pharmacy benefits, however, follow TRICARE’s own rules, and that is where weight loss injections such as Wegovy can become complicated. Recent policy updates have shifted how some obesity and cardiovascular prescriptions are reviewed, making it important to check the current formulary and authorization requirements before assuming a medication is covered.

What TRICARE For Life Means for Wegovy Coverage

TRICARE For Life is not a stand-alone health plan. It works with Medicare, but the TRICARE pharmacy benefit remains separate for many prescriptions. For Wegovy, coverage depends on the reason for the prescription, the beneficiary’s diagnosis, and the current TRICARE formulary. A prescription written only for weight loss may face different rules than one written to reduce cardiovascular risk in a patient with obesity and heart disease. Eligibility for TRICARE For Life generally requires Medicare Part A and Part B enrollment, and pharmacy claims still go through the TRICARE pharmacy contractor. Because rules can change, beneficiaries should verify coverage through the official TRICARE pharmacy portal or by calling the pharmacy contractor before starting a new injection.

How the TRICARE Pharmacy Formulary Works

The TRICARE formulary lists which medications are covered and under what conditions. Wegovy and other semaglutide products may be placed on a tier that requires prior authorization, step therapy, or quantity limits. Some drugs are non-formulary, meaning they are not routinely covered unless an exception is approved. The pharmacy channel also matters. A 30-day supply from a military pharmacy may have a different copay than a 90-day supply through home delivery or a retail network pharmacy. Non-network pharmacies usually cost more. For ongoing refills, home delivery is often encouraged because it can lower costs and reduce gaps in treatment.

Prescriptions, Prior Authorization, and Appeals

Most weight loss injections require a prescription from a licensed provider, and TRICARE often requires prior authorization before it will pay. The authorization request usually includes the patient’s body mass index, related conditions, previous treatments, and whether the drug is being used for an FDA-approved indication. If the request is denied, beneficiaries have the right to an appeals process. Appeals may involve a reconsideration, a peer-to-peer review, or a formal appeal with supporting medical records. Keeping a copy of the denial letter, the provider’s notes, and the prescription history can make the process smoother. Some appeals succeed when the provider documents that the medication is medically necessary and that other options were not effective or not tolerated.

Insurance Benefits, Copay, and Eligibility

TRICARE For Life eligibility is tied to Medicare and military retirement status, but the pharmacy benefit has its own cost-sharing structure. A copay can vary by drug tier, fill type, and whether the prescription is generic, brand-name, or non-formulary. Wegovy is a brand-name semaglutide injection, so it often falls into a higher cost tier. Beneficiaries should review their TRICARE insurance benefits each year, especially during open season or after a formulary update. Some patients may also have other prescription coverage, such as Medicare Part D or employer insurance, which can affect coordination of benefits. If a medication is not covered, a provider may recommend an alternative or help with an exception request.

Obesity, Semaglutide, and Telehealth Support

Obesity is a chronic condition, and semaglutide injections are one type of treatment that may be prescribed along with diet and activity changes. Wegovy is FDA-approved for chronic weight management in certain adults and for cardiovascular risk reduction in some patients with obesity and heart disease. Telehealth has made it easier to consult a provider about weight management, but not every telehealth platform is authorized to prescribe under TRICARE rules. Beneficiaries should ask whether the provider accepts TRICARE, whether the prescription can be sent to a TRICARE network pharmacy, and whether prior authorization support is included.

Refills and Real-World Cost Insights

Refills for Wegovy are typically handled in 28-day or 30-day increments, with some plans allowing 90-day supplies through home delivery. Real-world costs vary widely. Without insurance, brand-name weight loss injections have high list prices. With TRICARE, the copay may be much lower if the drug is covered and authorized, but prior authorization and formulary rules still apply. Compounded semaglutide is often marketed at lower prices, but it is not FDA-approved as a substitute and is generally not covered by TRICARE. The table below provides general estimates, not quotes.


Product/Service Provider Cost Estimation
Wegovy (semaglutide) Novo Nordisk List price about $1,349 per month; TRICARE copay may be lower if covered and authorized
Zepbound (tirzepatide) Eli Lilly List price about $1,059.87 per month; not routinely covered for weight loss by TRICARE
Saxenda (liraglutide) Novo Nordisk List price about $1,349 per month; coverage varies by plan and indication
Compounded semaglutide Various telehealth and compounding pharmacies Often $200 to $500 per month; not FDA-approved as a substitute and not covered by TRICARE

Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.

Staying current with TRICARE pharmacy updates can make a meaningful difference for beneficiaries who rely on Wegovy or other semaglutide injections. Checking the formulary, understanding prior authorization, and keeping appeals documentation ready can reduce confusion. Because coverage rules and prices can shift, a practical step is to confirm details directly with TRICARE and a qualified healthcare provider.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.